68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: Correlation of sst2 mRNA and SUV max

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 7, 2011, Pages 1224-1236

  Boy, Christian ^a   Heusner, Till A ^a   Poeppel, Thorsten D ^a   Redmann Bischofs, Anja ^b   Unger, Nicole ^b   Jentzen, Walter ^a   Brandau, Wolfgang ^a   Mann, Klaus ^b   Antoch, Gerald ^a   Bockisch, Andreas ^a   Petersenn, Stephan ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Normal values; PET CT; RT PCR; Somatostatin analogues; Somatostatin receptors; sst

Indexed keywords

GALLIUM 68; MESSENGER RNA; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GA(III) DOTATOC; GA(III)-DOTATOC; OCTREOTIDE; ORGANOMETALLIC COMPOUND; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY EXAMINATION; LIVER EXAMINATION; LUNG EXAMINATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORPHOLOGY; PANCREAS EXAMINATION; PHYSIOLOGICAL PROCESS; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SPLEEN EXAMINATION; STOMACH EXAMINATION; THYROID GLAND EXAMINATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PROTEIN TRANSPORT; REFERENCE VALUE; RETROSPECTIVE STUDY; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN TRANSPORT; RECEPTORS, SOMATOSTATIN; REFERENCE VALUES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79958046632     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1760-x     Document Type: Article

References (40)

1. D Hoyer GI Bell M Berelowitz J Epelbaum W Feniuk PP Humphrey AM O'Carroll YC Patel A Schonbrunn JE Taylor 1995 Classification and nomenclature of somatostatin receptors Trends Pharmacol Sci 16 86 88 7792934 10.1016/S0165-6147(00)88988-9 1:CAS:528:DyaK2MXltlSkurk%3D
2. MJ Lewin 1992 The somatostatin receptor in the GI tract Annu Rev Physiol 54 455 468 1348612 10.1146/annurev.ph.54.030192.002323 1:CAS:528: DyaK38XktVSqtLg%3D
3. YC Patel 1999 Somatostatin and its receptor family Front Neuroendocrinol 20 157 198 10433861 10.1006/frne.1999.0183 1:CAS:528:DyaK1MXkvVOrsLc%3D (Pubitemid 29362641)
4. N Ballian FC Brunicardi XP Wang 2006 Somatostatin and its receptors in the development of the endocrine pancreas Pancreas 33 1 12 16804406 10.1097/01.mpa.0000226894.16817.e8 1:CAS:528:DC%2BD28Xnsl2ms74%3D (Pubitemid 43995333)
5. JC Reubi B Waser JC Schaer JA Laissue 2001 Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur J Nucl Med 28 836 846 11504080 10.1007/s002590100541 1:CAS:528:DC%2BD3MXkvVWltL0%3D (Pubitemid 32662546)
6. G Burnstock 2009 Autonomic neurotransmission: 60 years since sir Henry Dale Annu Rev Pharmacol Toxicol 49 1 30 18834312 10.1146/annurev.pharmtox. 052808.102215 1:CAS:528:DC%2BD1MXisV2js7c%3D
7. J Van Op den Bosch D Adriaensen L Van Nassauw JP Timmermans 2009 The role(s) of somatostatin, structurally related peptides and somatostatin receptors in the gastrointestinal tract: a review Regul Pept 156 1 8 10.1016/j.regpep.2009.04.003
8. YC Patel CB Srikant 1997 Somatostatin receptors Trends Endocrinol Metab 8 398 405 18406829 10.1016/S1043-2760(97)00168-9 1:CAS:528:DyaK1cXhvFGlsbc%3D (Pubitemid 28160244)
9. JC Reubi JC Schar B Waser S Wenger A Heppeler JS Schmitt HR Macke 2000 Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use Eur J Nucl Med 27 273 282 10774879 10.1007/s002590050034 1:CAS:528: DC%2BD3cXhsVWns7w%3D (Pubitemid 30167697)
10. R Görges G Kahaly J Müller-Brand H Mäcke HW Roser A Bockisch 2001 Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer Thyroid 11 647 659 11484893 10.1089/105072501750362718 (Pubitemid 32701585)
11. M Gabriel A Oberauer G Dobrozemsky C Decristoforo D Putzer D Kendler C Uprimny P Kovacs R Bale IJ Virgolini 2009 68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy J Nucl Med 50 1427 1434 19690033 10.2967/jnumed.108.053421 1:CAS:528: DC%2BD1MXhtFOrtbrN
12. A Rominger T Saam E Vogl C Ubleis C la Fougère S Förster A Haug P Cumming MF Reiser K Nikolaou P Bartenstein M Hacker 2010 In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors J Nucl Med 51 193 197 20080898 10.2967/jnumed.109.070672
13. PM van Hagen VA Dalm F Staal LJ Hofland 2008 The role of cortistatin in the human immune system Mol Cell Endocrinol 286 141 147 18450367 10.1016/j.mce.2008.03.007
14. T Lincke J Singer R Kluge O Sabri R Paschke 2009 Relative quantification of indium-111 pentetreotide and gallium-68 DOTATOC uptake in the thyroid gland and association with thyroid pathologies Thyroid 19 381 389 19355828 10.1089/thy.2008.0389 1:CAS:528:DC%2BD1MXkt1Cgs7k%3D
15. VA Dalm PM van Hagen PM van Koetsveld S Achilefu AB Houtsmuller DH Pols AJ van der Lely SW Lamberts LJ Hofland 2003 Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells Am J Physiol Endocrinol Metab 285 E344 E353 12684217 1:CAS:528:DC%2BD3sXmsVahsLc%3D
16. M Hofmann H Maecke R Börner E Weckesser P Schöffski L Oei J Schumacher M Henze A Heppeler J Meyer H Knapp 2001 Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data Eur J Nucl Med 28 1751 1757 11734911 10.1007/s002590100639 1:CAS:528: DC%2BD3MXosFagurs%3D
17. J Ruf F Heuck J Schiefer T Denecke F Elgeti A Pascher M Pavel L Stelter S Kropf B Wiedenmann H Amthauer 2010 Impact of multiphase 68Ga-DOTATOC-PET/CT on therapy management in patients with neuroendocrine tumors Neuroendocrinology 91 101 109 19996582 10.1159/000265561 1:CAS:528:DC%2BC3cXotVWrtw%3D%3D
18. D Putzer M Gabriel B Henninger D Kendler C Uprimny G Dobrozemsky C Decristoforo RJ Bale W Jaschke IJ Virgolini 2009 Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy J Nucl Med 50 1214 1221 19617343 10.2967/jnumed.108.060236
19. VD Corleto M Falconi F Panzuto M Milione O De Luca P Perri R Cannizzaro C Bordi P Pederzoli A Scarpa G Delle Fave 2009 Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas Neuroendocrinology 89 223 230 18974627 10.1159/000167796 1:CAS:528:DC%2BD1MXisFSqsro%3D
20. R Barone F Borson-Chazot R Valkema S Walrand F Chauvin L Gogou LK Kvols EP Krenning F Jamar S Pauwels 2005 Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship J Nucl Med 46 Suppl 1 99S 106S 15653658 1:CAS:528:DC%2BD2MXhsVeksLc%3D (Pubitemid 47619025)
21. M Cremonesi F Botta A Di Dia M Ferrari L Bodei C De Cicco A Rossi M Bartolomei R Mei S Severi M Salvatori G Pedroli G Paganelli 2010 Dosimetry for treatment with radiolabelled somatostatin analogues. A review Q J Nucl Med Mol Imaging 54 37 51 20168285 1:STN:280:DC%2BC3c7hvVKrsQ%3D%3D
22. V Prasad RP Baum 2010 Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions Q J Nucl Med Mol Imaging 54 61 67 20168287 1:STN:280:DC%2BC3c7hvVKrtw%3D%3D
23. KP Zhernosekov DV Filosofov RP Baum P Aschoff H Bihl AA Razbash M Jahn M Jennewein F Rösch 2007 Processing of generator-produced 68Ga for medical application J Nucl Med 48 1741 1748 17873136 10.2967/jnumed.107.040378 1:CAS:528:DC%2BD2sXht1GlurnE (Pubitemid 47572722)
24. W Jentzen 2010 Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging Phys Med Biol 55 2365 2398 20360631 10.1088/0031-9155/55/8/016
25. CG Ziegler JW Brown AV Schally A Erler L Gebauer A Treszl L Young LM Fishman JB Engel HS Willenberg S Petersenn G Eisenhofer M Ehrhart-Bornstein SR Bornstein 2009 Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues Proc Natl Acad Sci U S A 106 15879 15884 19717419 10.1073/pnas.0907843106 1:CAS:528:DC%2BD1MXhtFOqsLzJ
26. B Ueberberg H Tourne A Redmann MK Walz KW Schmid K Mann S Petersenn 2005 Differential expression of the human somatostatin receptor subtypes sst1 to sst5 in various adrenal tumors and normal adrenal gland Horm Metab Res 37 722 728 16372224 10.1055/s-2005-921092 1:CAS:528:DC%2BD28XisVSjtw%3D%3D (Pubitemid 43028072)
27. B Ueberberg N Unger SY Sheu MK Walz KW Schmid W Saeger K Mann S Petersenn 2008 Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland Horm Metab Res 40 181 188 18246525 10.1055/s-2007-1004574 1:CAS:528:DC%2BD1cXlsFenur0%3D (Pubitemid 351690521)
28. D Campana V Ambrosini R Pezzilli S Fanti AM Labate D Santini C Ceccarelli F Nori R Franchi R Corinaldesi P Tomassetti 2010 Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors J Nucl Med 51 353 359 20150249 10.2967/jnumed.109.066662
29. S Koukouraki LG Strauss V Georgoulias M Eisenhut U Haberkorn A Dimitrakopoulou-Strauss 2006 Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy Eur J Nucl Med Mol Imaging 33 1115 1122 16763820 10.1007/s00259-006-0110-x 1:CAS:528:DC%2BD28XhtVahurvJ (Pubitemid 44484467)
30. S Froidevaux AN Eberle M Christe L Sumanovski A Heppeler JS Schmitt K Eisenwiener C Beglinger HR Mäcke 2002 Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model Int J Cancer 98 930 937 11948475 10.1002/ijc.10295 1:CAS:528: DC%2BD38Xis1OhurY%3D (Pubitemid 34286693)
31. RM Kessler JR Ellis Jr M Eden 1984 Analysis of emission tomographic scan data: limitations imposed by resolution and background J Comput Assist Tomogr 8 514 522 6609942 10.1097/00004728-198406000-00028 1:STN:280:DyaL2c3htlCntw%3D%3D (Pubitemid 14122897)
32. JC Reubi B Waser JC Schaer JA Laissue 2001 Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur J Nucl Med 28 836 846 11504080 10.1007/s002590100541 1:CAS:528:DC%2BD3MXkvVWltL0%3D (Pubitemid 32662546)
33. K Zilles N Palomero-Gallagher C Grefkes F Scheperjans C Boy K Amunts A Schleicher 2002 Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry Eur Neuropsychopharmacol 12 587 599 12468022 10.1016/S0924-977X(02)00108-6 1:CAS:528:DC%2BD38XptFeksbg%3D (Pubitemid 35408708)
34. E Ludvigsen R Olsson M Stridsberg ET Janson S Sandler 2004 Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of mice and rats J Histochem Cytochem 52 391 400 14966206 10.1177/002215540405200310 1:CAS:528:DC%2BD2cXhslOgtbg%3D (Pubitemid 38229104)
35. S Bhandari N Watson E Long S Sharpe W Zhong SZ Xu SL Atkin 2008 Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney J Histochem Cytochem 56 733 743 18443363 10.1369/jhc.2008.950998 1:CAS:528:DC%2BD1cXos1Cjtbk%3D (Pubitemid 351991086)
36. MJ Low 2004 Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders Best Pract Res Clin Endocrinol Metab 18 607 622 15533778 10.1016/j.beem.2004.08.005 1:CAS:528:DC%2BD2cXpsVOltrc%3D (Pubitemid 39481235)
37. MG Bryant SR Bloom JM Polak S Hobbs W Domschke S Domschke P Mitznegg H Ruppin L Demling 1983 Measurement of gut hormonal peptides in biopsies from human stomach and proximal small intestine Gut 24 114 119 6343197 10.1136/gut.24.2.114 1:CAS:528:DyaL3sXhtVWls78%3D (Pubitemid 13188252)
38. WH Smith RU Nair D Adamson MT Kearney SG Ball AJ Balmforth 2005 Somatostatin receptor subtype expression in the human heart: differential expression by myocytes and fibroblasts J Endocrinol 187 379 386 16423817 10.1677/joe.1.06082 1:CAS:528:DC%2BD28XitlOruw%3D%3D (Pubitemid 43020259)
39. WC Eckelman 1994 The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals Nucl Med Biol 21 759 769 9241652 10.1016/0969-8051(94)90047-7 1:CAS:528:DyaK2cXlslCjurg%3D (Pubitemid 24225391)
40. PT Meyer D Elmenhorst C Boy O Winz A Matusch K Zilles A Bauer 2007 Effect of aging on cerebral A1 adenosine receptors: a [18F]CPFPX PET study in humans Neurobiol Aging 28 1914 1924 16996650 10.1016/j.neurobiolaging.2006.08.005 1:CAS:528:DC%2BD2sXhtFKhsrfL (Pubitemid 47539692)